Scholarlink

Background <p>Medical scribes are increasingly used in outpatient clinics in the United States to reduce physician documentation burden, but their economic and operational impact remains inconsistently characterized. This scoping review synthesized evidence on the impact of medical scribes in outpatient care in the United States, focusing on physician productivity, documentation efficiency, and financial outcomes.</p> Methods <p>Nine databases were searched from January 2010 to September 2024 for English-language studies reporting economic or productivity outcomes of medical scribe use in outpatient settings. Two reviewers independently screened 1,945 unique records; data were charted using a piloted template and synthesized thematically.</p> Results <p>Twenty United States-based studies met the inclusion criteria: nine pre-post evaluations, five controlled cohort studies, two randomized controlled trials (RCTs), two microsimulation models, and two systematic reviews. Scribes consistently improved physician productivity: 19 of 20 studies (95%) reported increased work relative value units (wRVUs), higher patient throughput, and reduced documentation time. Clinician satisfaction improved across 9 studies; patient experience remained stable. Economic outcomes varied: 13 of 20 studies attempted return on investment (ROI) analysis, but only 6 included comprehensive costs (wages, training, licensing, turnover). Cost neutrality was achievable in high-volume clinics with predictable scheduling and unutilized capacity, but financial returns depended heavily on specialty, baseline productivity, and cost accounting rigor.</p> Conclusions <p>Medical scribes enhance operational efficiency and physician workflow in United States outpatient clinics, though economic value is context-dependent and incompletely documented. Standardised cost frameworks and controlled evaluations in non-United States health systems are needed to guide implementation decisions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The economic impact of medical scribe provision on physician productivity in outpatient clinics: a scoping review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月24日

查看全文
  • Ashwag Al Dhuhaibat,
  • Thomas Mason,
  • Erik Koornneef

摘要

Background

Medical scribes are increasingly used in outpatient clinics in the United States to reduce physician documentation burden, but their economic and operational impact remains inconsistently characterized. This scoping review synthesized evidence on the impact of medical scribes in outpatient care in the United States, focusing on physician productivity, documentation efficiency, and financial outcomes.

Methods

Nine databases were searched from January 2010 to September 2024 for English-language studies reporting economic or productivity outcomes of medical scribe use in outpatient settings. Two reviewers independently screened 1,945 unique records; data were charted using a piloted template and synthesized thematically.

Results

Twenty United States-based studies met the inclusion criteria: nine pre-post evaluations, five controlled cohort studies, two randomized controlled trials (RCTs), two microsimulation models, and two systematic reviews. Scribes consistently improved physician productivity: 19 of 20 studies (95%) reported increased work relative value units (wRVUs), higher patient throughput, and reduced documentation time. Clinician satisfaction improved across 9 studies; patient experience remained stable. Economic outcomes varied: 13 of 20 studies attempted return on investment (ROI) analysis, but only 6 included comprehensive costs (wages, training, licensing, turnover). Cost neutrality was achievable in high-volume clinics with predictable scheduling and unutilized capacity, but financial returns depended heavily on specialty, baseline productivity, and cost accounting rigor.

Conclusions

Medical scribes enhance operational efficiency and physician workflow in United States outpatient clinics, though economic value is context-dependent and incompletely documented. Standardised cost frameworks and controlled evaluations in non-United States health systems are needed to guide implementation decisions.